MIT Technology Review features the lab's cancer-diagnostic probiotic technology.

October 2, 2014

Research in the lab to develop diagnostic probiotics is featured in an article in the MIT Technology Review. Our prior synthetic biomarker work, described in a paper earlier this year, requires an injection of nanoparticles (see “A Paper Diagnostic for Cancer” also in the Tech Review). In new, as-yet-unpublished work, the lab is developing a way to deliver the synthetic biomarkers by modifying bacteria.